Larimar Therapeutics (LRMR) Cash from Investing Activities (2013 - 2025)
Larimar Therapeutics (LRMR) recorded Cash from Investing Activities of $100.31 million in FY2025, compared with -$85.39 million in FY2024.
Powered by 
Analysis
Larimar Therapeutics (LRMR) Cash from Investing Activities (2013 - 2025) Analysis & Trends
Starting with FY2012, Larimar Therapeutics' Cash from Investing Activities history includes 14 years.
- Annual Cash from Investing Activities has a five-year compound annual growth rate of 42.5% (FY2020 to FY2025).
- The FY2025 figure is the highest annual Cash from Investing Activities in data going back to FY2012.
- Per Business Quant data, LRMR's Cash from Investing Activities was -$85.39 million in FY2024, $33.35 million in FY2023, -$90.96 million in FY2022 and $24.17 million in FY2021 (+41.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | -15.40 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -1.11 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -5.60 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.11 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -2.91 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -569.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.35 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.11 Bn |
| 10 | Larimar Therapeutics | 307.49 Mn | -299.58 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 18.84 Mn |
| Mar 31, 2025 | 14.45 Mn |
| Dec 31, 2024 | 19.20 Mn |
| Sep 30, 2024 | 27.27 Mn |
| Jun 30, 2024 | -63.49 Mn |
| Mar 31, 2024 | -68.36 Mn |
| Dec 31, 2023 | -2.63 Mn |
| Sep 30, 2023 | -46.43 Mn |
| Jun 30, 2023 | -9.84 Mn |
| Mar 31, 2023 | 92.25 Mn |
| Dec 31, 2022 | -52.23 Mn |
| Sep 30, 2022 | -3.38 Mn |
| Dec 31, 2021 | 6.49 Mn |
| Sep 30, 2021 | -6.79 Mn |
| Jun 30, 2021 | 19.22 Mn |
| Mar 31, 2021 | 5.25 Mn |
| Dec 31, 2020 | -23.55 Mn |
| Sep 30, 2020 | -8,000.00 |
| Jun 30, 2020 | 41.42 Mn |
| Mar 31, 2020 | -778,000.00 |
API Access
Larimar Therapeutics Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=LRMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "LRMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=LRMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();